Valproate sodium and Augmentin '125' drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Valproate sodium (valproate sodium) and Augmentin '125' (amoxicillin; clavulanate potassium). Common drug interactions include anaemia among females and acute hepatic failure among males.

The phase IV clinical study analyzes what interactions people have when they take Valproate sodium and Augmentin '125'. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Valproate sodium?

Valproate sodium has active ingredients of valproate sodium. It is often used in epilepsy. eHealthMe is studying from 24,044 Valproate sodium users. Check the latest studies of Valproate sodium.

What is Augmentin '125'?

Augmentin '125' has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 10,452 Augmentin '125' users. Check the latest studies of Augmentin '125'.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 19, 2026

15 people who take Valproate sodium and Augmentin '125' together, and have interactions are studied.

Valproate sodium and Augmentin '125' drug interactions.

What are the common drug interactions of Valproate Sodium and Augmentin '125', by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
  3. Leukocytoclastic vasculitis (inflammation of small blood vessels (usually post-capillary venules in the dermis), characterized by palpable purpura)
  4. Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)
  5. Overdose
  6. Pancreatitis necrotising (inflammation of the pancreas cause death of tissue in pancreas)
  7. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  8. Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot)
  9. Abdominal pain
  10. Acidosis (build-up of carbon dioxide in the blood)

male:

  1. Acute hepatic failure
  2. Arthralgia (joint pain)
  3. Hypoxia (low oxygen in tissues)
  4. Lymphadenopathy (disease or enlargement of lymph nodes)
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  6. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
  7. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  8. Oedema peripheral (superficial swelling)
  9. Pain
  10. Pyrexia (fever)

What are the common drug interactions of Valproate Sodium and Augmentin '125', by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Abdominal pain
  2. Pancreatitis acute (sudden inflammation of pancreas)
  3. Acute hepatic failure

10-19:

n/a

20-29:

  1. Acidosis (build-up of carbon dioxide in the blood)
  2. Blood pressure decreased
  3. Depressed level of consciousness
  4. Overdose
  5. Oxygen saturation decreased
  6. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  7. Drug rash with eosinophilia and systemic symptoms (adverse drug reactions with rash)
  8. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  9. Lymphadenopathy (disease or enlargement of lymph nodes)
  10. Rash

30-39:

  1. Blood alkaline phosphatase increased
  2. Blood bilirubin increased
  3. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  4. Gamma-glutamyltransferase increased

40-49:

n/a

50-59:

  1. Blood creatine phosphokinase increased
  2. Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
  3. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  4. Dyspnoea (difficult or laboured respiration)
  5. Hypocapnia (level of carbon dioxide in the blood is lower than normal)
  6. Hypotension (abnormally low blood pressure)
  7. Hypoxia (low oxygen in tissues)
  8. Inferior vena caval occlusion
  9. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  10. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)

60+:

  1. Anaemia (lack of blood)
  2. Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
  3. Leukocytoclastic vasculitis (inflammation of small blood vessels (usually post-capillary venules in the dermis), characterized by palpable purpura)
  4. Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)
  5. Pancreatitis necrotising (inflammation of the pancreas cause death of tissue in pancreas)
  6. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  7. Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot)
  8. Neutropenia (an abnormally low number of neutrophils)
  9. Tardive dyskinesia (a disorder that involves involuntary movements)
  10. White blood cell count decreased

What are the existing conditions these people have? *

  1. Upper Respiratory Tract Infection: 2 people, 13.33%
  2. Neutropenic Infection (infection with less neutrophil numbers in blood): 2 people, 13.33%
  3. Multiple Myeloma (cancer of the plasma cells): 2 people, 13.33%
  4. Sleep Disorder: 1 person, 6.67%
  5. High Blood Cholesterol: 1 person, 6.67%
  6. Bipolar Disorder (mood disorder): 1 person, 6.67%
  7. Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 1 person, 6.67%
  8. Breakthrough Pain: 1 person, 6.67%
  9. Chest Pain: 1 person, 6.67%
  10. Depression: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Valproate sodium and Augmentin '125'?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Valproate sodium and Augmentin '125':

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Valproate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Augmentin '125':

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valproate sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Augmentin '125' and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on valproate sodium and amoxicillin; clavulanate potassium (the active ingredients of Valproate sodium and Augmentin '125', respectively), and Valproate sodium and Augmentin '125' (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: